Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Infant, Newborn, Diseases: later-stage trial registry

2 of 9 indexed Infant, Newborn, Diseases trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 2 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Infant, Newborn, Diseases: 9 US clinical trials tracked, 2 recruiting.

Infant, Newborn, Diseases is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is NICHD Neonatal Research Network, running 3 of these trials.

Enrollment posture brief

Registry condition infant-newborn-diseases

OPEN 2 | RECR 22% | LATE 2 | EARLY 1 | RANK #1916 | SPON 3

Nearest open-share peer: Acne (22% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Infant, Newborn, Disease (th…22%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Infant, Newborn, Diseases

Infant, Newborn, Diseases lists 2 open slots (22% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Infant, Newborn, Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Infant, Newborn, Diseases is recruiting below its size-band peers.

    2 of 9 indexed trials (22.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Infant, Newborn, Diseases research.

    NICHD Neonatal Research Network accounts for 3 of 9 trials (33.3%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Infant, Newborn, Diseases enrolment sits around 179 participants.

    Median target enrolment is 179 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.

  4. Infant, Newborn, Diseases research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 32

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 2

Named interventions

Most-linked intervention names on Infant, Newborn, Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Restricted red cell transfusion Procedure
1 trials
Liberal Cell Transfusion Procedure
1 trials
Fetoscopic laser surgery Procedure
1 trials
Mipomersen Sodium Drug
1 trials
Maternal Questionnaire Other
1 trials
Medical Record Data Extraction Other
1 trials
Point-of Care Blood Sugar Testing Other
1 trials
Video Electroencephalogram (EEG) Other
1 trials

US sites by state

Facility locations filed on Infant, Newborn, Diseases trials. A trial with sites in several states counts in each.

Texas 5 trials
Ohio 5 trials
New York 5 trials
North Carolina 5 trials
Alabama 5 trials
Pennsylvania 4 trials
California 4 trials
Utah 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Infant, Newborn, Diseases page

9 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infant, Newborn, Diseases condition card totals 9 registered trials; most-linked intervention Restricted red cell transfusion; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.